OncoArendi Therapeutics (OncoArendi) jest innowacyjną firmą biotechnologiczną, specjalizującą się w poszukiwaniu, rozwoju i komercjalizacji nowych leków stosowanych w terapii chorób zapalnych i nowotworowych. Model biznesowy OAT obejmuje odkrywanie i rozwój nowych leków w oparciu o najwyższą jakość chemii medycznej.
http://www.oncoarendi.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
14.4 seconds
16x16
32x32
ORDYNAT
Przemyslaw Pilaszek
Bart●●●●7/43
L●z , 92-533
PL
View this contact
ORDYNAT
Przemyslaw Pilaszek
Bart●●●●7/43
L●z , 92-533
PL
View this contact
Dinfo Systemy Internetowe
Sylwia Wieronska
Mos●●●a 5
Biel●●●●iala , slaskie, 43-300
PL
View this contact
ORDYNAT
Przemyslaw Pilaszek
Bart●●●●7/43
L●z , 92-533
PL
View this contact
BUY YOUR DOMAIN
13
YEARS
5
MONTHS
3
DAYS
KEY-SYSTEMS GMBH
WHOIS : whois.rrpproxy.net
REFERRED : http://www.key-systems.net
PAGES IN
THIS WEBSITE
5
SSL
EXTERNAL LINKS
2
SITE IP
85.128.156.43
LOAD TIME
14.376 sec
SCORE
6.2
Strona główna - OncoArendi Therapeutics | oncoarendi.com Reviews
https://oncoarendi.com
OncoArendi Therapeutics (OncoArendi) jest innowacyjną firmą biotechnologiczną, specjalizującą się w poszukiwaniu, rozwoju i komercjalizacji nowych leków stosowanych w terapii chorób zapalnych i nowotworowych. Model biznesowy OAT obejmuje odkrywanie i rozwój nowych leków w oparciu o najwyższą jakość chemii medycznej.
oncoarendi.com
OncoArendi Therapeutics | INVESTORS / OncoArendi Therapeutics
https://oncoarendi.com/investors--oncoarendi-therapeutics
INVESTORS / OncoArendi Therapeutics. OncoArendi Therapeutics has been a very attractive investment opportunity, offering its investors top level „first-in-class” drug discovery programs focused on anti-inflammatory targets and cancer immunotherapy. In addition OncoArendi can achieve a 7-fold risk reduction compared with its competitors from US or Western Europe. Fund as the lead investor of the Series A investment round.
OncoArendi Therapeutics | CAREERS / OncoArendi Therapeutics
https://oncoarendi.com/careers
CAREERS / OncoArendi Therapeutics. Apply for a job at OncoArendi. If you are interested in working with top-level team please fill in the above survey and submit your CV and motivation letter (in English or in Polish). PLEASE USE THE FORM BELOW OR SEND YOUR INQUIRY TO: contact@oncoarendi.com. ATTACHMENTS (CV, MOTIVATION LETTER, REFERENCES).
OncoArendi Therapeutics | ABOUT / OncoArendi Therapeutics
https://oncoarendi.com/about
ABOUT / OncoArendi Therapeutics. History and Business Model. OncoArendi Therapeutics (OAT) is an innovative biopharmaceutical company dedicated to developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. Founded in March 2012 OncoArendi Therapeutics (OAT) has thus far secured nearly 16 million PLN (about 4.5 million USD) in private financing. Currently its founders and the management team retain approx. 50% ownership. Main assets and competitive advantage. Access to non...
OncoArendi Therapeutics | Blog
https://oncoarendi.com/home
May 4, 2016. OncoArendi is a partner in a 8.3 million Horizon 2020 EU grant awarded to international ‘PRECIOUS’. Of the Radboud University Medical Center, the Netherlands. Read more here Press Release PRECIOUS.pdf. To learn more about the project, visit the EC website. April 30, 2016. OncoArendi moves into new laboratories at the University of Warsaw. In relation to the above transition, OncoArendi management informs that as of April 1, 2016, the company headquarters have moved to:. Zwirki i Wigury 101.
OncoArendi Therapeutics | TEAM / OncoArendi Therapeutics
https://oncoarendi.com/team1
TEAM / OncoArendi Therapeutics.
TOTAL PAGES IN THIS WEBSITE
5
Osiągnięcia i referencje | BMC – Biotech Management Consulting
http://biotechmanagement.pl/osiagniecia-i-referencje
BMC – Biotech Management Consulting. Do kogo się zwracamy? Nasi klienci i partnerzy. Nasi klienci i partnerzy. Nasz zespół (działający pod marką BTM Mazowsze i później BMC) przyczynił się do realizacji szeregu innowacyjnych projektów z zakresu szeroko pojętej biomedycyny i biotechnologii. Założyliśmy 4 spółki spin-off:. IMNTA Sp. z o.o. (rozwój nowych leków antybakteryjnych). GLIA Sp. z o.o. (rozwój nowych leków onkologicznych). Zainicjowaliśmy 2 współprace naukowo przemysłowe:. Jesteśmy bezpośrednio zaa...
TOTAL LINKS TO THIS WEBSITE
2
The ultimate tragedy is not the oppression and cruelty by the bad people but the silence over that by the good people [La peor tragedia no es la opresion y la crueldad de la gente mala sino el silencio de la gente buena] | In the End, we will remember not
The ultimate tragedy is not the oppression and cruelty by the bad people but the silence over that by the good people [La peor tragedia no es la opresion y la crueldad de la gente mala sino el silencio de la gente buena]. In the End, we will remember not the words of our enemies, but the silence of our friends. [Al final, no recordamos las palabras de nuestros enemigos sino el silencio de nuestros amigos.]. All in the family. May 22, 2015. The Face of Corruption. Huyendo en Panamá o es en Barcelona?
Oncoanestesia | Serviço de Anestesiologia do Instituto Português de Oncologia de Lisboa
Serviço de Anestesiologia do Instituto Português de Oncologia de Lisboa. Skip to primary content. Workshop – Analgesia 2017. Manual de Procedimentos 2016. App ABS – Anesthesia Basic Support. Todas as semanas reveja uma personalidade que por motivos muito diversos está ligada à História da Anestesia. Esta semana, o escolhido é Pierre-Cyprien Oré. Hospital de Santo André, 9 de Fevereiro de 1874, 17 horas. O professor Pierre-Cyprien. Em 16 de fevereiro deste mesmo ano, Oré revela esta experiência à Academia...
Main Menu
Strategic Answers Inc. (SAI) is a leading provider of oncology forecasting and strategic planning solutions to global pharmaceutical and biotechnology companies. With over 60 years of Oncology expertise within their management team, SAI has developed OncoAnswers. A comprehensive offering to help drug manufacturers manage the substantial challenges. Faced when developing and marketing oncology therapeutics in the rapidly changing era of personalized medicine. Uncovering Treatable Patient Populations.
Centro Oncológico Antônio Ermírio de Moraes - COAEM
Sobre o Centro Oncológico. Bp coaem 960x298 paciente rita. Http:/ www.beneficencia.org.br/ Portal/Principal/Arquivos/Download/Upload/bpsp coaem pdf institucional 2642.pdf. Bp coaem 960x298 paciente heloisa. Http:/ www.beneficencia.org.br/ Portal/Principal/Arquivos/Download/Upload/bpsp coaem pdf institucional 2642.pdf. Bp coaem 960x298 buzaid. Http:/ www.beneficencia.org.br/ Portal/Principal/Arquivos/Download/Upload/bpsp coaem pdf institucional 2642.pdf. Bp coaem 960x298 maluf. Bp coaem 960x298 younes.
Indels/SNV/SNP positions to Primers for Illumnia MiSeq DeepSeq
Project 1 : TOV-SNV2. Project 2 : Automated primer design pipeline v0. Project 3 : Automated primer design pipeline v2. Project 4 : Automated primer design pipeline v3 - using Pleiades webPcr server. Primer3-2.3.5 - manual. BCR - Sep upload.
Strona główna - OncoArendi Therapeutics
Model i Rozwój Biznesowy. OncoArendi Therapeutics (OncoArendi) jest innowacyjną firmą biotechnologiczną, specjalizującą się w poszukiwaniu, rozwoju i komercjalizacji nowych leków stosowanych w terapii chorób zapalnych i nowotworowych. Model biznesowy OAT obejmuje odkrywanie i rozwój nowych leków w oparciu o najwyższą jakość chemii medycznej i przedklinicznych badań biologicznych, naukową współpracę z najlepszymi ośrodkami i liderami opinii w obszarze badanych chorób oraz efektywne wykorzystanie specj...
On Coarse
Angling Tuition in Essex and East Anglia. Graham and Steve at 'On Coarse' are two life-long fisherman, dedicated to imparting knowledge to anglers of all ages. Specialising in all year round coarse fishing on commercial fisheries, ponds, lakes and rivers. How does it work? Steve and I will provide the venue, equipment, licences, bait and tuition to start you on your fishing journey. Learn the art of fresh water angling, from setting up, to landing. Fish of your dreams. Here's what we can offer. The progr...
Adjuvant Calculator - Oncology Apps - ONCOassist
353 21 731 9541 info@oncoassist.com. What others say about us. 8220;I love the comprehensive nature of the app – I don’t need to use multiple apps to stage then look for prognosis, discuss adjuvant benefits, calculate BSA, GFR, carboplatin doses, etc. It also has the CTCAE criteria to grade adverse effects built within it when seeing trial patients. Dr Bryan A. Chan. Chief and Clinical Fellow, Medical Oncology - Princess Margaret Cancer Centre , Canada. Consultant Oncologist - Dorset Cancer Centre. This ...
OncoAssistance | Comunicazione nelle Bioscienze e in Medicina Oncologica
Comunicazione nelle Bioscienze e in Medicina Oncologica. Piccoli Punti per la Prevenzione del Melanoma alla Marcia del Sorriso di Romano d’Ezzelino. La Prevenzione del Melanoma corre anche quest’anno alla Marcia del Sorriso. E i medici del Centro Regionale Melanoma dell’Istituto Oncologico Veneto (IOV) di Padova, saranno a disposizione dei partecipanti alla prossima edizione della Marcia del Sorriso per un controllo della pelle gratuito. Diretto dal Prof. Carlo Riccardo Rossi. Alla popolazione del Veneto.
Oncologistas Associados - Centro Integrado de Oncologia - São Paulo
oncoast.com - This website is for sale! - oncoast Resources and Information.
2015 Mail to Webmaster.
